Direct oral anticoagulants in patients affected by major congenital thrombophilia
Conclusions: No patient presented hemorrhagic or thrombotic complications during DOAC therapy. DOACs have proven to be effective and safe in this real-life series of patients with major thrombophilia.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Source Type: research
More News: Hematology | Infectious Diseases | Thrombosis | Vitamin K | Vitamin K Deficiency | Vitamins